Global disease burden and its attributable risk factors of peripheral arterial disease

被引:12
作者
You, Yayu [1 ]
Wang, Zhuo [1 ,2 ]
Yin, Zhehui [1 ]
Bao, Qinyi [1 ]
Lei, Shuxin [1 ]
Yu, Jiaye [1 ]
Xie, Xiaojie [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Cardiol, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 4, Int Inst Med, Sch Med, Yiwu 322000, Peoples R China
关键词
CHRONIC KIDNEY-DISEASE; SCIENTIFIC STATEMENT; SOCIOECONOMIC-STATUS; RENAL-INSUFFICIENCY; SMOKING-CESSATION; MORTALITY; HEALTH; EPIDEMIOLOGY; PREVALENCE; MANAGEMENT;
D O I
10.1038/s41598-023-47028-5
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Peripheral arterial disease (PAD) is a prevalent subtype of atherosclerotic cardiovascular diseases. It is crucial to assess the PAD-related burden and its attributable risk factors. We use the Global Burden of Disease study 2019 database to calculate the incidence, prevalence, mortality, disability-adjusted life years (DALY), attributable risk factors and estimated annual percentage change. The disease burden of PAD grows significantly with age accompanied by prominent heterogeneity between male and female. Despite the increase in the absolute numbers of disease burden from 1990 to 2019, the global PAD-related age-standardized death rate (ASDR) and age-standardized disability-adjusted life years rate (ASDALYR) have a mild downward trend from 1990 to 2019, which negatively correlated with sociodemographic index (SDI). Smoking and high systolic blood pressure (SBP) were the primary attributable risk factors for males (ASDR: 33.4%; ASDALYR: 43.4%) and females (ASDR: 25.3%; ASDALYR: 27.6%), respectively. High fasting plasma glucose (FPG) had become the second risk factor for ASDR (males: 28.5%; females: 25.2%) and ASDALYR (males: 29.3%; females: 26.3%) with an upward tendency. Low-middle SDI regions were predicted to have the most remarkable upward trend of PAD-related burden caused by high FPG. Smoking caused more disease burden in males before 85-90 years old and females before 65-70 years old, while high FPG and high SBP caused more burden after that. The patterns of PAD-related burden and its attributable risk factors are heterogeneous across ages, genders, and SDI regions. To reduce disease burden, tailored strategies should be implemented.
引用
收藏
页数:13
相关论文
共 60 条
[1]  
Abbafati C, 2020, LANCET, V396, P1204
[2]   Morbidity and mortality associated with atherosclerotic peripheral artery disease: A systematic review [J].
Agnelli, Giancarlo ;
Belch, Jill J. F. ;
Baumgartner, Iris ;
Giovas, Periklis ;
Hoffmann, Ulrich .
ATHEROSCLEROSIS, 2020, 293 :94-100
[3]   Health Disparities in Peripheral Artery Disease: A Scientific Statement From the American Heart Association [J].
Allison, Matthew G. ;
Armstrong, David P. ;
Goodney, Philip M. ;
Hamburg, Naomi ;
Kirksey, Lee J. ;
Lancaster, Kristie I. ;
Mena-Hurtado, Carlos ;
Misra, Sanjay J. ;
Treat-Jacobson, Diane T. ;
White Solaru, Khendi .
CIRCULATION, 2023, 148 (03) :286-296
[4]  
[Anonymous], 2019, World Bank Data Help Desk
[5]   Smoking cessation is associated with decreased mortality and improved amputation-free survival among patients with symptomatic peripheral artery disease [J].
Armstrong, Ehrin J. ;
Wu, Julie ;
Singh, Gagan D. ;
Dawson, David L. ;
Pevec, William C. ;
Amsterdam, Ezra A. ;
Laird, John R. .
JOURNAL OF VASCULAR SURGERY, 2014, 60 (06) :1565-1571
[6]  
Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI [10.1161/CIR.0000000000000485, 10.1161/CIR.0000000000000530, 10.1161/CIR.0000000000000558]
[7]   Evidence-Based Medical Management of Peripheral Artery Disease [J].
Bevan, Graham H. ;
Solaru, Khendi T. White .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40 (03) :541-553
[8]   Models for estimating and projecting global, regional and national prevalence and disease burden of asthma: a systematic review [J].
Bhuia, Mohammad Romel ;
Islam, Atiqul ;
Nwaru, Bright, I ;
Weir, Christopher J. ;
Sheikh, Aziz .
JOURNAL OF GLOBAL HEALTH, 2020, 10 (02) :1-29
[9]   Long-term effects of ramipril on cardiovascular events and on diabetes - Results of the HOPE study extension [J].
Bosch, J ;
Lonn, E ;
Pogue, J ;
Arnold, JMO ;
Dagenais, GR ;
Yusuf, S .
CIRCULATION, 2005, 112 (09) :1339-1346
[10]   Time trends in peripheral artery disease incidence, prevalence and secondary preventive therapy: a cohort study in The Health Improvement Network in the UK [J].
Cea-Soriano, Lucia ;
Fowkes, F. Gerry R. ;
Johansson, Saga ;
Allum, Alaster M. ;
Garcia Rodriguez, Luis Alberto .
BMJ OPEN, 2018, 8 (01)